Navigation Links
PolySkope Labs Announces AOAC PTM Submission of the World's First Comprehensive Multiplex Pathogen Detection Method for Food Safety Industry
Date:3/7/2017

OKLAHOMA CITY, March 7, 2017 /PRNewswire/ -- PolySkope Labs, a company that develops novel multiplex food safety assays, announced today they have submitted for regulatory approval the world's first comprehensive multiplex pathogen detection method. PolySkope Labs has applied for AOAC Performance Tested Method (PTM) status for the PolySkope 1.0 Pathogen Detection Method in a variety of matrices. PolySkope 1.0 is the first comprehensive and modular multiplex RT-PCR pathogen detection method for the most common foodborne pathogens. The Company anticipates launch of PolySkope 1.0 in Q3-2017.

PolySkope's CSO, Michael Centola, stated "We're thrilled to announce the regulatory submission and upcoming launch of the first true multiplex method in food safety. Our passion is translating our team's expertise in multiplex diagnostic assay development from the clinical space into food safety applications." "PolySkope 1.0 will reduce the cost, materials and complexity needed to make food safer."

Continue Reading
PolySkope 1.0 Multiplex Kit and Multiplex Enrichment Media (PMEM)
PolySkope 1.0 Multiplex Kit and Multiplex Enrichment Media (PMEM)

In an industry first, PolySkope 1.0 simultaneously detects Shiga Toxin E. coli, Salmonella spp. and Listeria monocytogenes in a single multiplex, modular RT-PCR reaction, using a single, overnight enrichment. PolySkope's revolutionary Multiplex Enrichment Media (PMEM) allows simultaneous enrichment of all organisms in the same bag. End users can detect 1, 2 or 3 pathogens by selection on the instrument; the protocol and sample prep are identical.

PolySkope 1.0 provides enormous savings for end-users by reducing up to 3-fold the media, reagents, equipment, technician labor, equipment, protocol complexity and regulatory burden for pathogen testing. This provides a streamlined and simplified workflow essential to high-throughput food safety labs.

PolySkope has selected the latest ThermoFisher/ABI QuantStudio5 instrument as its preferred platform at launch. This instrument is optimized for multiplexes and allows for secure local and remote (cloud) data storage. It also allows both remote run and analysis for use in satellite labs. Launch of PolySkope 1.0 is slated for Q3-2017.

About PolySkope Labs
PolySkope was founded in 2011 by an experienced group of scientists with proven track records of developing multiplex diagnostic assays in the clinical space (Crescendo, Intergenetics). Their singular goal is translating multiplex methods into food safety. PolySkope 1.0 represents a starting point for their revolutionizing of food safety testing. AOAC PTM status and U.S. launch are expected in Q3-2017, with availability in Europe and Asia scheduled for Q2 2018.

Visit http://polyskopelabs.com for information

Contact:
Cyrus Zegrati
405-633-0540
cyrus@polyskopelabs.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/polyskope-labs-announces-aoac-ptm-submission-of-the-worlds-first-comprehensive-multiplex-pathogen-detection-method-for-food-safety-industry-300418709.html


'/>"/>
SOURCE PolySkope Labs
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. Kindred Biosciences Announces Global Sponsorship of International Society of Equine Locomotor Pathology
2. Inspirata Announces the Completion of the Largest Ever Single-Site Deployment of Digital Pathology Imaging Devices
3. DuPont Announces New, Complete Solutions to Maximize Soybean Yields
4. SENOMYX ANNOUNCES FOURTH QUARTER AND FULL YEAR 2016 FINANCIAL RESULTS
5. ProMIS Neurosciences Announces Appointment of Anthony Giovinazzo to its Board of Directors
6. Origin Agritech Announces Date for Special Meeting of Shareholders
7. Sangamo Therapeutics Announces Presentation At The Cowen And Company 37th Annual Health Care Conference
8. BioAmber Announces Webcast of Fiscal Fourth Quarter And Full 2016 Financial Results
9. MiMedx Audit Committee Announces Completion Of Its Investigation
10. SELLAS Life Sciences Announces Updated Positive Phase 2 Data Reinforcing Meaningful Clinical Benefit of its WT1 Immunotherapeutic Anti-cancer Treatment in Multiple Myeloma Patients
11. Illustris Launches Novel Technology And Announces Veteran Industry Leadership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2018)... SAN FRANCISCO (PRWEB) , ... November 14, 2018 ... ... Indiegogo campaign, bringing the world’s first self-learning snore-reduction mask to the public. It ... to a poorer quality of sleep for themselves and their partner. The resulting ...
(Date:11/13/2018)... ... November 13, 2018 , ... Renowned Honolulu veterinarian, Dr. Patrick ... island of Kauai. Dr. Leadbeater, of Kahala Pet Hospital on Oahu, ... Recently, he began traveling to the island of Kauai on an almost weekly basis ...
(Date:11/13/2018)... ... 2018 , ... AseptiScope(TM), Inc. announces it is advancing its ... last week, confirm pose a significant health risk. The two large clinical ... are often improperly or rarely disinfected. In the AJIC November 6 issue, investigators ...
(Date:11/13/2018)... ... 12, 2018 , ... Dr. Dan Myers, a well-respected regional ... welcomes new patients for MTM® Clear Aligners. Offering a variety of orthodontics solutions, ... the Sandy Springs and Alpharetta areas. Constantly on the forefront of innovative dental ...
Breaking Biology Technology:
(Date:11/6/2018)... , ... November 06, 2018 , ... uBiome, the leader ... and Biophysics at the University of California, San Francisco (UCSF) and Co-President of Chan ... scientific adviser to uBiome since 2013, and we are honored that he is expanding ...
(Date:11/3/2018)... ... 01, 2018 , ... The Conference Forum announces the keynote-speaking ... 2019 at the Crowne Plaza Times Square in New York City. , The ... Global Franchise Leader in Cancer Immunotherapy Biomarkers and IO360° Plenary Chair, Priti ...
(Date:11/3/2018)... ... November 01, 2018 , ... Dr. Bryan Choi, a postdoctoral fellow in ... Harvard Medical School, has been awarded the 2018 xCELLigence Immunotherapy Research Grant by ... Medicine, is a promising form of treatment designed to harness a patient’s own immune ...
Breaking Biology News(10 mins):